Depleting the chemokine CCL2, known to be increased in ALS patients and involved in CD56bright NK cell recruitment, significantly reduced the percentage of NK cells in the CNS of these mice during early disease, suggesting a role for this chemokine in the migration of NK cells into the CNS in ALS [231]. Here, CCL2 is linked to amyotrophic lateral sclerosis.